S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Evolus (EOLS) News Today

$11.53
-0.03 (-0.26%)
(As of 05:21 PM ET)
SourceHeadline
investing.com logoEvolus reports 6-month efficacy of Jeuveau in glabellar lines study
investing.com - April 18 at 11:14 PM
MarketBeat logoShort Interest in Evolus, Inc. (NASDAQ:EOLS) Declines By 6.6%
americanbankingnews.com - April 18 at 5:10 AM
finance.yahoo.com logoEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for "Extra-Strength" 40U Formulation of Jeuveau®
finance.yahoo.com - April 17 at 8:32 PM
businesswire.com logoEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
businesswire.com - April 17 at 4:05 PM
marketbeat.com logoEvolus, Inc. (NASDAQ:EOLS) Sees Significant Decrease in Short Interest
marketbeat.com - April 16 at 12:23 PM
marketbeat.com logoVanguard Group Inc. Grows Stock Holdings in Evolus, Inc. (NASDAQ:EOLS)
marketbeat.com - April 13 at 4:31 AM
businesswire.com logoEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com - April 12 at 4:05 PM
MarketBeat logoEvolus (NASDAQ:EOLS) Given Buy Rating at Needham & Company LLC
americanbankingnews.com - April 11 at 5:14 AM
marketbeat.com logoNeedham & Company LLC Reaffirms "Buy" Rating for Evolus (NASDAQ:EOLS)
marketbeat.com - April 10 at 8:17 AM
marketbeat.com logoEvolus, Inc. (NASDAQ:EOLS) is Stonepine Capital Management LLC's Largest Position
marketbeat.com - April 9 at 9:43 PM
finance.yahoo.com logoEvolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company
finance.yahoo.com - April 6 at 2:55 PM
marketbeat.com logoEvolus (NASDAQ:EOLS) Shares Gap Down to $13.76
marketbeat.com - April 3 at 1:35 PM
insidertrades.com logoInsider Selling: Evolus, Inc. (NASDAQ:EOLS) Insider Sells 6,236 Shares of Stock
insidertrades.com - March 30 at 7:38 AM
marketbeat.com logoEvolus, Inc. (NASDAQ:EOLS) Insider David Moatazedi Sells 6,236 Shares
marketbeat.com - March 29 at 9:16 PM
finance.yahoo.com logoEvolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
finance.yahoo.com - March 26 at 10:00 AM
insidertrades.com logoEvolus, Inc. (NASDAQ:EOLS) CFO Sells $78,954.24 in Stock
insidertrades.com - March 24 at 5:58 AM
marketbeat.com logoInsider Selling: Evolus, Inc. (NASDAQ:EOLS) CFO Sells 5,672 Shares of Stock
marketbeat.com - March 21 at 7:57 PM
msn.com logoEvolus (NASDAQ:EOLS): An Attractive Aesthetics Stock for Growth Investors
msn.com - March 21 at 8:11 AM
seekingalpha.com logoEvolus: Smooth Progress As Management Targets $700m Aesthetics Franchise Revenues By 2028
seekingalpha.com - March 20 at 5:09 PM
marketbeat.com logoWalleye Capital LLC Grows Stock Holdings in Evolus, Inc. (NASDAQ:EOLS)
marketbeat.com - March 17 at 4:20 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Sangamo Biosciences (SGMO) and Evolus (EOLS)
markets.businessinsider.com - March 14 at 10:40 AM
wsj.com logoEvolus Inc.
wsj.com - March 12 at 8:31 PM
benzinga.com logoLatest News for Evolus Stock (NASDAQ:EOLS)
benzinga.com - March 12 at 8:31 PM
markets.businessinsider.com logoEvolus Poised for Growth: Buy Rating Affirmed with $25 Price Target Amid Profitability Forecast and Competitive Market Positioning
markets.businessinsider.com - March 11 at 6:48 PM
markets.businessinsider.com logoEvolus Reports Pricing Of $50 Mln Underwritten Offering Of Common Stock
markets.businessinsider.com - March 11 at 8:47 AM
markets.businessinsider.com logoEvolus (EOLS) Receives a Buy from Barclays
markets.businessinsider.com - March 11 at 8:47 AM
msn.com logoEvolus prices stock offering to raise about $50M
msn.com - March 11 at 8:47 AM
marketbeat.com logoSchroder Investment Management Group Purchases 115,647 Shares of Evolus, Inc. (NASDAQ:EOLS)
marketbeat.com - March 11 at 7:22 AM
businesswire.com logoEvolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
businesswire.com - March 11 at 7:00 AM
finance.yahoo.com logoAnalyst Estimates: Here's What Brokers Think Of Evolus, Inc. (NASDAQ:EOLS) After Its Full-Year Report
finance.yahoo.com - March 10 at 2:31 PM
marketbeat.com logoSchonfeld Strategic Advisors LLC Purchases Shares of 131,342 Evolus, Inc. (NASDAQ:EOLS)
marketbeat.com - March 10 at 5:45 AM
finance.yahoo.com logoEvolus Full Year 2023 Earnings: In Line With Expectations
finance.yahoo.com - March 9 at 12:15 PM
msn.com logoEvolus, Inc. (NASDAQ:EOLS) Q4 2023 Earnings Call Transcript
msn.com - March 8 at 5:50 PM
businesswire.com logoEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com - March 8 at 4:05 PM
markets.businessinsider.com logoEvolus Poised for Growth: Surpassing Q4 Expectations and Accelerating Profitability
markets.businessinsider.com - March 8 at 12:44 PM
finance.yahoo.com logoEvolus Inc (EOLS) Reports Record Revenues in Q4 and Full Year 2023, Eyes Profitability in 2024
finance.yahoo.com - March 8 at 2:34 AM
investorplace.com logoEOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q4 2023
investorplace.com - March 7 at 11:06 PM
seekingalpha.com logoEvolus, Inc. 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 7 at 10:41 PM
msn.com logoEvolus GAAP EPS of -$0.21 in-line, revenue of $61M in-line
msn.com - March 7 at 9:29 PM
benzinga.com logoRecap: Evolus Q4 Earnings
benzinga.com - March 7 at 9:29 PM
businesswire.com logoEvolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
businesswire.com - March 7 at 4:05 PM
msn.com logoEvolus Q4 2023 Earnings Preview
msn.com - March 6 at 10:19 PM
markets.businessinsider.com logoEvolus earnings: here's what to expect
markets.businessinsider.com - March 6 at 5:19 PM
benzinga.com logoEarnings Outlook For Evolus
benzinga.com - March 6 at 5:19 PM
marketbeat.com logoEvolus (NASDAQ:EOLS) Reaches New 12-Month High at $15.20
marketbeat.com - March 4 at 10:52 AM
investing.com logoEvolus reports dermal filler edges out Restylane-L in study
investing.com - March 3 at 12:18 AM
marketbeat.com logoEvolus (NASDAQ:EOLS) Given "Buy" Rating at HC Wainwright
marketbeat.com - March 1 at 2:51 PM
finance.yahoo.com logoEvolus Announces Results from European Head-to-Head Filler Trial
finance.yahoo.com - March 1 at 10:06 AM
finance.yahoo.com logoEvolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences
finance.yahoo.com - February 27 at 1:06 PM
businesswire.com logoEvolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences
businesswire.com - February 27 at 8:30 AM
Get Evolus News Delivered to You Automatically

Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

EOLS Media Mentions By Week

EOLS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EOLS
News Sentiment

0.79

0.52

Average
Medical
News Sentiment

EOLS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EOLS Articles
This Week

8

2

EOLS Articles
Average Week

Get Evolus News Delivered to You Automatically

Sign up to receive the latest news and ratings for EOLS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:EOLS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners